Peter Kissinger

Chembio Diagnostics, Inc. engages in the developing, manufacturing, marketing, and licensing of rapid medical tests. It offers rapid point-of-care tests for infectious, tropical and fever, and respiratory diseases, handheld analyzers, and veterinary products. The firm distributes its products to hospitals and clinics, physician offices, clinical laboratories, public health organizations, government agencies, and consumers. The company was founded in 1985 and is headquartered in Medford, NY.

Chembio Diagnostic Systems, Inc. engages in the development, manufacture, and commercialization of point-of-care diagnostic tests and technology for the detection of infectious diseases. It offers human and veterinary diagnostic products. The company was founded in 1985 and is headquartered in Medford, NY.

The American Association for the Advancement of Science provides science related journal, program, and education services. The firm also promotes the responsible use of science in public policy. The company was founded in 1848 and is headquartered in Washington, DC.

Indiana Proteomics Consortium LLC, founded in 2002, engages in research of technologies that could involve proteomics. The private company is based in West Lafayette, IN.

Prosolia, Inc. develops direct mass spectrometric solutions. Its applications offer molecular imaging, forensic toxicology molecular pathology, industrial research, preclinical research, and drug determination. The firm products are DESI 2dimesional, velox 360 and flowprobe. The company is headquartered in Indianapolis, IN.

Good AI Capital LLC (Good AI Capital) is a venture capital firm founded in 2017 by Darwin Ling. The firm is headquartered in San Francisco, California.